Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 26;11(26):15497-15511.
doi: 10.1039/d0ra10728j.

Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of Mycobacterium tuberculosis and paediatric brain tumour cells

Affiliations

Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of Mycobacterium tuberculosis and paediatric brain tumour cells

Shahinda S R Alsayed et al. RSC Adv. .

Abstract

The omnipresent threat of tuberculosis (TB) and the scant treatment options thereof necessitate the development of new antitubercular agents, preferably working via a novel mechanism of action distinct from the current drugs. Various studies identified the mycobacterial membrane protein large 3 transporter (MmpL3) as the target of several classes of compounds, including the indole-2-caboxamides. Herein, several indoleamide analogues were rationally designed, synthesised, and evaluated for their antitubercular and antitumour activities. Compound 8g displayed the highest activity (MIC = 0.32 μM) against the drug-sensitive (DS) Mycobacterium tuberculosis (M. tb) H37Rv strain. This compound also exhibited high selective activity towards M. tb over mammalian cells [IC50 (Vero cells) = 40.9 μM, SI = 128], suggesting its minimal cytotoxicity. In addition, when docked into the MmpL3 active site, 8g adopted a binding profile similar to the indoleamide ligand ICA38. A related compound 8f showed dual antitubercular (MIC = 0.62 μM) and cytotoxic activities against paediatric glioblastoma multiforme (GBM) cell line KNS42 [IC50 (viability) = 0.84 μM]. Compound 8f also showed poor cytotoxic activity against healthy Vero cells (IC50 = 39.9 μM). Compounds 9a and 15, which were inactive against M. tb, showed potent cytotoxic (IC50 = 8.25 and 5.04 μM, respectively) and antiproliferative activities (IC50 = 9.85 and 6.62 μM, respectively) against KNS42 cells. Transcriptional analysis of KNS42 cells treated with compound 15 revealed a significant downregulation in the expression of the carbonic anhydrase 9 (CA9) and the spleen tyrosine kinase (SYK) genes. The expression levels of these genes in GBM tumours were previously shown to contribute to tumour progression, suggesting their involvement in our observed antitumour activities. Compounds 9a and 15 were selected for further evaluations against three different paediatric brain tumour cell lines (BT12, BT16 and DAOY) and non-neoplastic human fibroblast cells HFF1. Compound 9a showed remarkable cytotoxic (IC50 = 0.89 and 1.81 μM, respectively) and antiproliferative activities (IC50 = 7.44 and 6.06 μM, respectively) against the two tested atypical teratoid/rhabdoid tumour (AT/RT) cells BT12 and BT16. Interestingly, compound 9a was not cytotoxic when tested against non-neoplastic HFF1 cells [IC50 (viability) = 119 μM]. This suggests that an indoleamide scaffold can be fine-tuned to confer a set of derivatives with selective antitubercular and/or antitumour activities.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1. Potent anti-TB compounds reported in the literature.
Fig. 2
Fig. 2. A diagram summarising the design strategy of the target indoleamides.
Scheme 1
Scheme 1. General synthetic routes for compounds 8a–h, 9a,b, and 11a,b.
Scheme 2
Scheme 2. General synthetic routes for compounds 15 and 20.
Fig. 3
Fig. 3. Re-docking of ICA38 (Cyan) in the MmpL3 active site (A), showing the S3–S5 subsites. The ICA38 top pose was oriented almost at the same position as the original ICA38 co-crystallised ligand (purple). The two key Asp–Tyr pairs, implicated in proton relay, located in the S4 subsite are marked in orange hashed ovals. The putative binding interactions of ICA38 with the MmpL3 binding pocked is represented in 2D on the right panel (B).
Fig. 4
Fig. 4. Superposition of the top ranked docking pose of 8f (A) and 8g (B) (brown) and the co-crystallised ligand ICA38 (purple), showing the putative binding mode of both compounds in the MmpL3 active site.

References

    1. World Health Organization, Global Tuberculosis Report, Geneva, 2020, retrieved from https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-en...
    1. Dheda K. Barry III C. E. Maartens G. Lancet. 2016;387:1211–1226. doi: 10.1016/S0140-6736(15)00151-8. - DOI - PMC - PubMed
    1. Keshavjee S. Farmer P. E. N. Engl. J. Med. 2012;367:931–936. doi: 10.1056/NEJMra1205429. - DOI - PubMed
    1. Caminero J. A. Sotgiu G. Zumla A. Migliori G. B. Lancet Infect. Dis. 2010;10:621–629. doi: 10.1016/S1473-3099(10)70139-0. - DOI - PubMed
    1. Chim N. Torres R. Liu Y. Capri J. Batot G. Whitelegge J. P. Goulding C. W. Chem. Biol. 2015;22:1098–1107. doi: 10.1016/j.chembiol.2015.07.013. - DOI - PMC - PubMed